95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.55%
Revenue growth at 50-75% of RGLD's 16.06%. Martin Whitman would worry about competitiveness or product relevance.
42.29%
Gross profit growth above 1.5x RGLD's 15.09%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
31.40%
EBIT growth below 50% of RGLD's 3342.73%. Michael Burry would suspect deeper competitive or cost structure issues.
31.40%
Operating income growth under 50% of RGLD's 3342.73%. Michael Burry would be concerned about deeper cost or sales issues.
19.33%
Net income growth under 50% of RGLD's 282.57%. Michael Burry would suspect the firm is falling well behind a key competitor.
-73.33%
Negative EPS growth while RGLD is at 263.87%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-69.23%
Negative diluted EPS growth while RGLD is at 262.87%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.16%
Share reduction more than 1.5x RGLD's 9.64%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.51%
Reduced diluted shares while RGLD is at 10.31%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
16.30%
OCF growth under 50% of RGLD's 3994.07%. Michael Burry might suspect questionable revenue recognition or rising costs.
17.36%
FCF growth under 50% of RGLD's 102.73%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
78.28%
10Y revenue/share CAGR under 50% of RGLD's 633.89%. Michael Burry would suspect a lasting competitive disadvantage.
140.24%
5Y revenue/share CAGR similar to RGLD's 131.62%. Walter Schloss might see both companies benefiting from the same mid-term trends.
48.10%
3Y revenue/share CAGR 1.25-1.5x RGLD's 40.29%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
252.65%
5Y OCF/share CAGR 1.25-1.5x RGLD's 205.54%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
55.50%
3Y OCF/share CAGR at 50-75% of RGLD's 86.71%. Martin Whitman would suspect weaker recent execution or product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
285.93%
5Y net income/share CAGR above 1.5x RGLD's 23.90%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
50.62%
Positive short-term CAGR while RGLD is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
440.98%
5Y equity/share CAGR at 75-90% of RGLD's 551.65%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
60.50%
3Y equity/share CAGR at 50-75% of RGLD's 117.98%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
47.50%
AR growth well above RGLD's 18.04%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
4.08%
Asset growth well under 50% of RGLD's 17.31%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.83%
Under 50% of RGLD's 13.47%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-75.82%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-14.97%
We cut SG&A while RGLD invests at 15.68%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.